Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes

Neuropsychopharmacology

Volumn 33, Issue 12, 2008, Pages 2993-3009

  Katsel, Pavel ^a,b   Davis, Kenneth L ^a   Li, Celeste ^a   Tan, Weilun ^a   Greenstein, Elizabeth ^a   Kleiner Hoffman, Lisa B ^a   Haroutunian, Vahram ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Cingulate cortex; Gene expression; Myelin; Oligodendrocyte; Schizophrenia

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1C; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; RETINOBLASTOMA PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MITOSIS INDEX; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; UPREGULATION;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; CELL CYCLE; CELL CYCLE PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENES, CDC; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MICE; MICE, KNOCKOUT; MYELIN PROTEINS; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; RECEPTORS, CELL SURFACE; RETINOBLASTOMA PROTEIN; SCHIZOPHRENIA;

EID: 53949100073     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.19     Document Type: Article

References (109)

1. Aberg K, Saetre P, Jareborg N, Jazin E (2006a). Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci USA 103: 7482-7487.
2. Aberg K, Saetre P, Lindholm E, EkholmB, Pettersson U, Adolfsson R et al (2006b). Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet 141: 84-90.
3. Arnold SE, Trojanowski JQ (1996). Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol (Berl) 92: 217-231.
4. Arquint M, Roder J, Chia LS, Down J, Wilkinson D, Bayley H et al (1987). Molecular-cloning and primary structure of myelin-associated glycoprotein. Proc Natl Acad Sci USA 84: 600-604.
5. Aston C, Jiang L, Sokolov BP (2004). Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 77: 858-866.
6. Attia J, Tropak M, Johnson PW, Newerly-Abranow W, Pawson T, Roder JC et al (1989). Modulated adhesion: a proposal for the role of myelin-associated glycoprotein in myelin wrapping. Clin Chem 35: 717-720.
7. Bahn S, Jones PB (2003). Gene expression in schizophrenia and bipolar disorder. Schizo Res 60: 60.
8. Barta PE, Pearlson GD, Powers RE, Richards SS, Tune LE (1990). Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 147: 1457-1462.
9. Bartsch S, Montag D, Schachner M, Bartsch U (1997). Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Br Res 762: 231-234.
10. Bartsch U (1996). Myelination and axonal regeneration in the central nervous system of mice deficient in the myelin-associated glycoprotein. J Neurocytol 25: 303-313.
11. Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J (2003). Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 53: 412-421.
12. Baumann N, Pham-Dinh D (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871-927.
13. Benes FM (1989). Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull 15: 585-593.
14. Benes FM (1999). Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol Psychiatry 46: 589-599.
15. Benes FM, Davidson J, Bird ED (1986). Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 43: 31-35.
16. Benes FM, Matzilevich D, Burke RE, Walsh J (2006). The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 11: 241-251.
17. Benes FM, Turtle M, Khan Y, Farol P (1994). Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 51: 477-484.
18. Benes FM, Vincent SL, Todtenkopf M (2001). The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50: 395-406.
19. Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S (2003). DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch Gen Psychiatry 60: 359-364.
20. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Soc Ser B (Methodol) 57: 289-300.
21. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003). A comparison of normalization methods for high-density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
22. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA et al (1998). MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. NeuroReport 9: 425-430.
23. Budhraja V, Spitznagel E, Schaiff WT, Sadovsky Y (2003). Incorporation of gene-specific variability improves expression analysis using high-density DNA microarrays. BMC Biol 1: 1.
24. Cotter D, Mackay D, Landau S, Kerwin R, Everall I (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58: 545-553.
25. Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M et al (1999). Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281: 1401-1406.
26. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof P et al (2003). White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arc Gen Psychiatry 60: 443-456.
27. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V (2006). Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in schizophrenia. Neurobiol Dis 79: 157-173.
28. Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V (2001). N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 158: 1400-1410.
29. Dracheva S, McGurk SR, Davis KL, Haroutunian V (2005). mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of of elderly schizophrenics. J Neurosci Res 79: 868-878.
30. Dugas JC, Ibrahim A, Barres BA (2007). A crucial role for p57Kip2 in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 27: 6185-6196.
31. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA (2006). Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26: 10967-10983.
32. Dyer CA, Kendler A, Jean-Guillaume D, Awatramani R, Lee A, Mason LM et al (2000). GFAP-positive and myelin marker-positive glia in normal and pathologic environments. J Neurosci Res 60: 412-426.
33. Flynn SW, Lang DJ, MacKay AL, Goghari V, Vavasour IM, Whittall KP et al (2003). Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8: 811-820.
34. Foong J, Maier M, Barker GJ, Brocklehurst S, Miller DH, Ron MA (2000). In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatr 68: 70-74.
35. Foong J, Symms MR, Barker GJ, Maier M, Woermann FG, Miller DH et al (2001). Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 124: 882-892.
36. Franklin KBJ, Paxinos G (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York.
37. Friston KJ, Frith CD (1995). Schizophrenia: a disconnection syndrome? Clin Neurosci 3: 89-97.
38. Gallo V, Ghiani CA (2000). Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci 21: 252-258.
39. Gao G, Bracken AP, Burkard K, Pasini D, Classon M, Attwooll C et al (2003). NPAT expression is regulated by E2F and is essential for cell cycle progression. Mol Cell Biol 23: 2821-2833.
40. Geng Y, Eaton EN, Picon M, Roberts JM, Lundberg AS, Gifford A et al (1996). Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1180.
41. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A et al (1999). Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2: 861-863.
42. Goldman-Rakic PS (1999). The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 46: 650-661.
43. Goldman-Rakic PS, Selemon LD (1997). Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull 23: 437-458.
44. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98: 4746-4751.
45. Haroutunian V, Davis KL (2000). Neuropathology of schizophrenia. In: Breier A, Tran PV, Herrera J, Bymaster F, Tollefson GD (eds). Current Issues in the Psychopharmacology of Schizophrenia. Williams and Wilkins: Baltimore. pp 57-70.
46. Haroutunian V, Davies PJ, Vianna C, Buxbaum JD, Purohit DP (2006a). Tau protein abnormalities associated with the progression of Alzheimer disease type dementia. Neurobiol Aging 28: 1-7.
47. Haroutunian V, Katsel P, Dracheva S, Davis KL (2006b). The human homolog of QKI gene affected in the severe dysmyelination 'quaking' mouse phenotype is downregulated in multiple brain regions in schizophrenia. Am J Psychiat 163: 1834-1837.
48. Haroutunian V, Katsel P, Schmeidler J (2007). Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. Neurobiol Aging, advance online publication; doi:10.1016/j.neurobiolaging.2007.07. 021.
49. Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M et al (1998). Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol 55: 1185-1191.
50. Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M et al (1999). Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 56: 713-718.
51. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Part 4): 593-624.
52. Herrup K, Yang Y (2007). Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 8: 368-378.
53. Hinman JD, Peters A, Cabral H, Rosene DL, Hollander W, Rasband MN et al (2006). Age-related molecular reorganization at the node of Ranvier. J Comp Neurol 495: 351-362.
54. Hof PR, Haroutunian V, Friedrich Jr VL, Byne W, Buitron C, Perl DP et al (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53: 1075-1085.
55. Huttenlocher PR (1979). Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res 163: 195-205.
56. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al (2003). Exploration, normalization, and summaries of high-density oligonucleotide array probe level data. Biostatistics 4: 249-264.
57. Iwamoto K, Bundo M, Yamada K, Takao H, Iwayama-Shigeno Y, Yoshikawa T et al (2005). DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25: 5376-5381.
58. Katsel P, Davis KL, Gorman JM, Haroutunian V (2005a). Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizo Res 77: 241-252.
59. Katsel P, Davis KL, Haroutunian V (2004). Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63: 41-81.
60. Katsel P, Davis KL, Haroutunian V (2005b). Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions: A gene ontology study. Schizo Res 79: 157-173.
61. Katsel P, Li C, Haroutunian V (2007). Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 32: 845-856.
62. Katsel PL, Davis KL, Haroutunian V (2005c). Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63: 41-82.
63. Kornhuber J, Schultz A, Wiltfang J, Meineke I, Gleiter CH, Zochling R et al (1999). Persistence of haloperidol in human brain tissue. Am J Psychiatry 156: 885-890.
64. Kovelman JA, Scheibel AB (1984). A neurohistological correlate of schizophrenia. Biol Psychiatry 19: 1601-1621.
65. Larocca JN, Rodriguez-Gabin AG (2002). Myelin biogenesis: vesicle transport in oligodendrocytes. Neurochem Res 27: 1313-1329.
66. Larocque D, Galarneau A, Liu HN, Scott M, Almazan G, Richard S (2005). Protection of p27(Kip1) mRNA by quaking RNA-binding proteins promotes oligodendrocyte differentiation. Nat Neurosci 8: 27-33.
67. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, Trapp B et al (1994). Myelination in the absence of myelin-associated glycoprotein. Nature 369: 747-750.
68. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A (1999). Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen psychiatry 56: 367-374.
69. Liu Y, Wu Y, Lee JC, Xue H, Pevny LH, Kaprielian Z et al (2002). Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 40: 25-43.
70. Lundberg AS, Weinberg RA (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18: 753-761.
71. Mariani TJ, Budhraja V, Mecham BH, Gu CC, Watson MA, Sadovsky Y (2003). A variable fold change threshold determines significance for expression microarrays. FASEB J 17: 321-323.
72. Meyer-Lindenberg A, Poline JB, Kohn PD, Holt JL, Egan MF, Weinberger DR et al (2001). Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 158: 1809-1817.
73. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991). The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
74. Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE et al (2008). Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res 98: 129-138.
75. Miyakawa T, Sumiyoshi S, Deshimaru M, Suzuki T, Tomonari H (1972). Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathol (Berl) 20: 67-77.
76. Nikulina EM, Skrinskaya JA, Avgustinovich DF, Popova NK (1995). Dopaminergic brain system in the quaking mutant mouse. Pharmacol Biochem Behav 50: 333-337.
77. Noveroske JK, Hardy R, Dapper JD, Vogel H, Justice MJ (2005). A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination. Mamm Genome 16: 672-682.
78. Pavlidis P, Lewis DP, Noble WS (2002). Exploring gene expression data with class scores. Pac Symp Biocomput 7: 474-485.
79. Pavlidis P, Qin J, Arango V, Mann JJ, Sibille E (2004). Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res 29: 1213-1222.
80. Peters A (2002). The effects of normal aging on myelin and nerve fibers: a review. J Neurocytol 31: 581-593.
81. Peters A, Sethares C (2003). Is there remyelination during aging of the primate central nervous system? J Comp Neurol 460: 238-254.
82. Peters A, Sethares C (2004). Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb Cortex 14: 995-1007.
83. Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL (1998). Alzheimer's disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry 55: 205-211.
84. Raedler TJ, Knable MB, Weinberger DR (1998). Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 8: 157-161.
85. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C (2002). Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57: 127-138.
86. Rajkowska G, Selemon LD, Goldman-Rakic PS (1998). Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 55: 215-224.
87. Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM et al (2007). Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci USA 104: 8131-8136.
88. Segal D, Haroutunian V, Schmitz C, Hof P (2006). Spatial distribution and density of oligodendrocytes in the cingulum bundle is unaltered in schizophrenia. Abstr Soc Neurosci.
89. Selemon LD, Goldman-Rakic PS (1999). The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45: 17-25.
90. Selemon LD, Rajkowska G (2003). Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder. Curr Mol Med 3: 427-436.
91. Selemon LD, Rajkowska G, Goldman-Rakic PS (1998). Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol 392: 402-412.
92. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B (2004). Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 161: 882-888.
93. Stevens JR (1973). An anatomy of schizophrenia? Arch Gen Psychiatry 29: 177-189.
94. Sugai T, Kawamura M, Iritani S, Araki K, Makifuchi T, Imai C et al (2004). Prefrontal abnormality of schizophrenia revealed by DNA microarray impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 1025: 84-91.
95. Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH (2000). The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Res Brain Res Rev 31: 364-370.
96. Terry R, DeTeresa R, Hansen L (1987). Neocortical cell counts in normal human adult aging. Ann Neurol 21 No 6: 530-539.
97. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798-805.
98. Torrey EF, Peterson MR (1974). Schizophrenia and the limbic system. Lancet 2: 942-946.
99. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V et al (2001). Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55: 597-610.
100. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the stanley neuropathology consortium. Schizo Res 67: 269-275.
101. Vostrikov VM, Uranova NA, Orlovskaya DD (2007). Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 94: 273-280.
102. Weinberger DR (1995). Neurodevelopmental prespectives in schizophrenia. In: Bloom FE and Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York. pp 1171-1184.
103. Weinberger DR (1999). Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 45: 395-402.
104. Weinberger DR, Lipska BK (1995). Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 16: 87-110.
105. Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W et al (2007). Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry, advance online publication 7 August 2007; doi:10.1038/sj.mp.4002064.
106. Yang Y, Varvel NH, Lamb BT, Herrup K (2006). Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci 26: 775-784.
107. Zarkowska T, Mittnacht S (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272: 12738-12746.
108. Zeman W, Innes JRM (1963). Craigie's Neuroanatomy of the Rat. Academic Press: New York.
109. Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA et al (2000). NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev 14: 2283-2297.